These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1562 related items for PubMed ID: 18201600

  • 1. Outcomes of placing dental implants in patients taking oral bisphosphonates: a review of 115 cases.
    Grant BT, Amenedo C, Freeman K, Kraut RA.
    J Oral Maxillofac Surg; 2008 Feb; 66(2):223-30. PubMed ID: 18201600
    [Abstract] [Full Text] [Related]

  • 2. A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics.
    Pazianas M, Miller P, Blumentals WA, Bernal M, Kothawala P.
    Clin Ther; 2007 Aug; 29(8):1548-58. PubMed ID: 17919538
    [Abstract] [Full Text] [Related]

  • 3. The nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in dental implant patients: a South Australian case series.
    Goss A, Bartold M, Sambrook P, Hawker P.
    J Oral Maxillofac Surg; 2010 Feb; 68(2):337-43. PubMed ID: 20116705
    [Abstract] [Full Text] [Related]

  • 4. Survival of dental implants among post-menopausal female dental school patients taking oral bisphosphonates: a retrospective study.
    Famili P, Quigley S, Mosher T.
    Compend Contin Educ Dent; 2011 Feb; 32(6):E106-9. PubMed ID: 23738968
    [Abstract] [Full Text] [Related]

  • 5. Bisphosphonates and dental implants: current problems.
    Flichy-Fernández AJ, Balaguer-Martínez J, Peñarrocha-Diago M, Bagán JV.
    Med Oral Patol Oral Cir Bucal; 2009 Jul 01; 14(7):E355-60. PubMed ID: 19561566
    [Abstract] [Full Text] [Related]

  • 6. The role of surgical resection in the management of bisphosphonate-related osteonecrosis of the jaws.
    Carlson ER, Basile JD.
    J Oral Maxillofac Surg; 2009 May 01; 67(5 Suppl):85-95. PubMed ID: 19371819
    [Abstract] [Full Text] [Related]

  • 7. Avascular mandibular osteonecrosis in association with bisphosphonate therapy: a report on four patients.
    Friedrich RE, Blake FA.
    Anticancer Res; 2007 May 01; 27(4A):1841-5. PubMed ID: 17649782
    [Abstract] [Full Text] [Related]

  • 8. Oral bisphosphonates as a cause of bisphosphonate-related osteonecrosis of the jaws: clinical findings, assessment of risks, and preventive strategies.
    Assael LA.
    J Oral Maxillofac Surg; 2009 May 01; 67(5 Suppl):35-43. PubMed ID: 19371813
    [Abstract] [Full Text] [Related]

  • 9. Dental endosseous implants in patients on bisphosphonate therapy.
    Scully C, Madrid C, Bagan J.
    Implant Dent; 2006 Sep 01; 15(3):212-8. PubMed ID: 16966893
    [Abstract] [Full Text] [Related]

  • 10. Bisphosphonate-associated osteonecrosis: a clinician's reference to patient management.
    Grewal VS, Fayans EP.
    Todays FDA; 2008 Aug 01; 20(8):38-41, 43-6. PubMed ID: 18767452
    [Abstract] [Full Text] [Related]

  • 11. Safety of oral bisphosphonates: controlled studies on alveolar bone.
    Jeffcoat MK.
    Int J Oral Maxillofac Implants; 2006 Aug 01; 21(3):349-53. PubMed ID: 16796276
    [Abstract] [Full Text] [Related]

  • 12. Osteonecrosis of the maxilla and mandible in patients with advanced cancer treated with bisphosphonate therapy.
    Estilo CL, Van Poznak CH, Wiliams T, Bohle GC, Lwin PT, Zhou Q, Riedel ER, Carlson DL, Schoder H, Farooki A, Fornier M, Halpern JL, Tunick SJ, Huryn JM.
    Oncologist; 2008 Aug 01; 13(8):911-20. PubMed ID: 18695259
    [Abstract] [Full Text] [Related]

  • 13. Osteonecrosis of the jaw in patients receiving intravenous or oral bisphosphonates.
    King AE, Umland EM.
    Pharmacotherapy; 2008 May 01; 28(5):667-77. PubMed ID: 18447663
    [Abstract] [Full Text] [Related]

  • 14. Bisphosphonate-induced osteonecrosis of the jaw.
    Krueger CD, West PM, Sargent M, Lodolce AE, Pickard AS.
    Ann Pharmacother; 2007 Feb 01; 41(2):276-84. PubMed ID: 17299010
    [Abstract] [Full Text] [Related]

  • 15. Nd:YAG laser biostimulation in the treatment of bisphosphonate-associated osteonecrosis of the jaw: clinical experience in 28 cases.
    Vescovi P, Merigo E, Manfredi M, Meleti M, Fornaini C, Bonanini M, Rocca JP, Nammour S.
    Photomed Laser Surg; 2008 Feb 01; 26(1):37-46. PubMed ID: 18248160
    [Abstract] [Full Text] [Related]

  • 16. Bisphosphonate-induced osteonecrosis of the jaw: a medical enigma?
    Siddiqi A, Payne AG, Zafar S.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Sep 01; 108(3):e1-8. PubMed ID: 19570696
    [Abstract] [Full Text] [Related]

  • 17. Oral bisphosphonate-associated osteonecrosis of the jaw after implant surgery: a case report and literature review.
    Bedogni A, Bettini G, Totola A, Saia G, Nocini PF.
    J Oral Maxillofac Surg; 2010 Jul 01; 68(7):1662-6. PubMed ID: 20561470
    [Abstract] [Full Text] [Related]

  • 18. Oral bisphosphonates and dental implants: a retrospective study.
    Bell BM, Bell RE.
    J Oral Maxillofac Surg; 2008 May 01; 66(5):1022-4. PubMed ID: 18423296
    [Abstract] [Full Text] [Related]

  • 19. Implant placement with or without simultaneous tooth extraction in patients taking oral bisphosphonates: postoperative healing, early follow-up, and the incidence of complications in two private practices.
    Fugazzotto PA, Lightfoot WS, Jaffin R, Kumar A.
    J Periodontol; 2007 Sep 01; 78(9):1664-9. PubMed ID: 17760533
    [Abstract] [Full Text] [Related]

  • 20. Bisphosphonate-associated osteonecrosis of mandibular and maxillary bone: an emerging oral complication of supportive cancer therapy.
    Migliorati CA, Schubert MM, Peterson DE, Seneda LM.
    Cancer; 2005 Jul 01; 104(1):83-93. PubMed ID: 15929121
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 79.